205 related articles for article (PubMed ID: 36548287)
21. Hereditary cancer syndromes, their testing and prevention.
Foretová L
Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
[TBL] [Abstract][Full Text] [Related]
22. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
23. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
24. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
25. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
26. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
International Mismatch Repair Consortium
Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
[TBL] [Abstract][Full Text] [Related]
27. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
28. Genetic anticipation in Swedish Lynch syndrome families.
von Salomé J; Boonstra PS; Karimi M; Silander G; Stenmark-Askmalm M; Gebre-Medhin S; Aravidis C; Nilbert M; Lindblom A; Lagerstedt-Robinson K
PLoS Genet; 2017 Oct; 13(10):e1007012. PubMed ID: 29088233
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
30. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
31. Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.
Courtney E; Chin XW; Yuen J; Li ST; Chen Y; Allen JC; Tan V; Lim GH; Ngeow J
Fam Cancer; 2018 Oct; 17(4):621-626. PubMed ID: 29368260
[TBL] [Abstract][Full Text] [Related]
32. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
[TBL] [Abstract][Full Text] [Related]
33. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
Lynch HT; Casey MJ; Snyder CL; Bewtra C; Lynch JF; Butts M; Godwin AK
Mol Oncol; 2009 Apr; 3(2):97-137. PubMed ID: 19383374
[TBL] [Abstract][Full Text] [Related]
34. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.
Dominguez-Valentin M; Sampson JR; Seppälä TT; Ten Broeke SW; Plazzer JP; Nakken S; Engel C; Aretz S; Jenkins MA; Sunde L; Bernstein I; Capella G; Balaguer F; Thomas H; Evans DG; Burn J; Greenblatt M; Hovig E; de Vos Tot Nederveen Cappel WH; Sijmons RH; Bertario L; Tibiletti MG; Cavestro GM; Lindblom A; Della Valle A; Lopez-Köstner F; Gluck N; Katz LH; Heinimann K; Vaccaro CA; Büttner R; Görgens H; Holinski-Feder E; Morak M; Holzapfel S; Hüneburg R; Knebel Doeberitz MV; Loeffler M; Rahner N; Schackert HK; Steinke-Lange V; Schmiegel W; Vangala D; Pylvänäinen K; Renkonen-Sinisalo L; Hopper JL; Win AK; Haile RW; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Wadt K; Therkildsen C; Okkels H; Ketabi Z; Moreira L; Sánchez A; Serra-Burriel M; Pineda M; Navarro M; Blanco I; Green K; Lalloo F; Crosbie EJ; Hill J; Denton OG; Frayling IM; Rødland EA; Vasen H; Mints M; Neffa F; Esperon P; Alvarez K; Kariv R; Rosner G; Pinero TA; Gonzalez ML; Kalfayan P; Tjandra D; Winship IM; Macrae F; Möslein G; Mecklin JP; Nielsen M; Møller P
Genet Med; 2020 Jan; 22(1):15-25. PubMed ID: 31337882
[TBL] [Abstract][Full Text] [Related]
35. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):e143-e149. PubMed ID: 31764758
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.
Beard VK; Bedard AC; Nuk J; Lee PWC; Hong Q; Bedard JEJ; Sun S; Schrader KA
CMAJ Open; 2020; 8(4):E637-E642. PubMed ID: 33077534
[TBL] [Abstract][Full Text] [Related]
37. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793
[TBL] [Abstract][Full Text] [Related]
38. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
39. Genomics of Hereditary Colorectal Cancer: Lessons Learnt from 25 Years of the Singapore Polyposis Registry.
Chew MH; Tan WS; Liu Y; Cheah PY; Loi CT; Tang CL
Ann Acad Med Singap; 2015 Aug; 44(8):290-6. PubMed ID: 26477961
[TBL] [Abstract][Full Text] [Related]
40. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
